Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS
· Delayed Price · Currency is USD
0.1495
+0.0063 (4.36%)
Apr 2, 2025, 1:15 PM EST
Nymox Pharmaceutical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
13.54M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 16.04M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.60M |
| American Oncology Network | 1.76B |
| Longduoduo Company | 6.01M |
Nymox Pharmaceutical News
- 22 days ago - Nymox Announces Dismissal of Delaware Action Against Ascella - GlobeNewsWire
- 3 months ago - NYMOX Announces Trading Resumed and New Listing on OTCQB Market - GlobeNewsWire
- 7 months ago - Nymox Announces Filing of Annual Report - GlobeNewsWire
- 9 months ago - Nymox Annual Report - GlobeNewsWire
- 9 months ago - Nymox Required to Resubmit Application to DKMA - GlobeNewsWire
- 1 year ago - Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages - GlobeNewsWire
- 1 year ago - Nymox December 27 Message to Shareholders - GlobeNewsWire
- 1 year ago - Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others - GlobeNewsWire